Novo Nordisk sues Hims & Hers over alleged unsafe Wegovy and Ozempic knock‑offs

Novo Nordisk and Amazon Web Services (AWS) have announced a strategic partnership to accelerate drug discovery and modernise Novo Nordisk’s operations through agentic AI and cloud technologies.

The European Commission has adopted the recent Committee for Medicinal Products for Human Use (CHMP) positive opinion recommending the approval of a type II variation for IMVANEX (MVA-BN) smallpox and mpox vaccine, extending the current marketing authorization to include children 2 to less than 12 years of age.

Swedish Orphan Biovitrum and Innate Pharma have entered a strategic partnership to enable initiation of the TELLOMAK-3 confirmatory Phase 3 study in cutaneous T cell lymphoma (CTCL).

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Lu AH69593, the company's lead oral orexin 2 receptor agonist and one of several investigational compounds in Lundbeck’s development portfolio for sleep-wake disorders.

Medivir has received a Notice of Allowance from the US Patent and Trademark Office for its patent application covering the combination of fostroxacitabine bralpamide (fostrox) and lenvatinib in hepatocellular carcinoma and liver metastases.

Pharmability has received approval from the Swedish Medical Products Agency to start a Phase Ib clinical trial of its lead candidate TIR-C in atopic dermatitis, marking the company’s move from preclinical to clinical development.

Diamyd Medical has outlined key learnings from the interim analysis of its Phase 3 DIAGNODE-3 trial, saying the findings may help inform future GAD65-based antigen-specific immunotherapy studies in recent-onset type 1 diabetes.